Thyroid-stimulating antibody may affect proto-oncogenes such as RET and TRK during the development of thyroid cancer in hyperthyroidism, and an increased thyroid-stimulating hormone level may lead to nodule and cancer growth in patients with hypothyroidism25. Here, RET is linked to hyperthyroidism.